|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:212-213
© 2005 The American Association for Thoracic Surgery
Brief Communication |
Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany.
Received for publication October 7, 2004; accepted for publication November 23, 2004. * Address for reprints: Uwe Klima, MD, Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany (Email: klima@thg.mh-hannover.de).
| The first 20% of the full text of this article appears below. |
Aortic valve replacement using the pulmonary autograft as described by Ross1
in 1967 is an excellent permanent therapy for aortic valve disease, particularly in young patients. This procedure facilitates the omission of anticoagulation. The pulmonary autograft displays a superior longevity and excellent hemodynamic properties in combination with a low incidence of thromboembolism compared with all other aortic valve replacement procedures. However, its success is dictated by the suitability of the pulmonary autograft before the switch to the aortic position; a normal pulmonary valve (PV) without anatomic abnormalities is a prerequisite for the achievement of a satisfying operative and hemodynamic result.
We report on the postoperative outcome and midterm follow-up (4 years) of a 48-year-old female patient who underwent
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |